Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA

FDA recall notice · announced July 11, 2012 · Mcneil Consumer Healthcare, Div Of Mcneil-ppc

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA

Reason for recall

Defective Container; damaged blister units

Notes

Distribution: Nationwide
Lot/code information: Lot #CMF023, Expiration 07/13.
Quantity: 53,892 packages
Status: Terminated
Products in this recall event:
- Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA (D-1404-2012)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.